GXN: Plate, Cranioplasty, Preformed, Non-Alterable

Product code GXN, “Plate, Cranioplasty, Preformed, Non-Alterable” in FDA's classification database, is a Class II device type under 21 CFR 882.5330 (preformed nonalterable cranioplasty plate), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 57 clearances under GXN, 34 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
GXN
Regulation
21 CFR 882.5330
Class
II
Panel
Neurology
Clearances
57
Most recent
Jun 25, 2026
Median review, last 2 years
193 days
Third-party review
Not eligible
Implant
Yes

What it covers

A preformed nonalterable cranioplasty plate is a device that is implanted in a patient to repair a skull defect and is constructed of a material, e.g., stainless steel or vitallium, that cannot be altered or reshaped at the time of surgery without changing the chemical behavior of the material.

The identification in 21 CFR 882.5330, preformed nonalterable cranioplasty plate. FDA gives GXN no definition of its own, so the regulation’s describes it.

FDA flags GXN devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K260709ClearFit Ti Ring 14mm (171750);ClearFit Ti Ring 14mm with Slot (171751);ClearFit Ti Ring 20mm (171752);ClearFit Ti Ring 20mm with Slot (171753);ClearFit Ti Ring 30mm (171754)Longeviti Neuro SolutionsJun 25, 2026Traditional
K2531163D MAC Titanium Cranial Plate (TCP) SystemThe Surgeon General, Department of the Army (TSG-DA)Jun 18, 2026Traditional
K252251EASYMADE-TICG Bio Co., Ltd.Apr 9, 2026Traditional
K252958METICULY Patient-specific titanium mesh implantMeticuly Co., Ltd.Jan 14, 2026Traditional
K243715Synthes Patient Specific ImplantsSynthes GmbHNov 12, 2025Traditional
K252573KLS Martin Cranial Implants - MR Conditional; K944565: KLS-Martin Micro Osteosynthesis System (1.5MM); K971297: KLS Martin Centre-Drive Drill-Free Screw; K060177: KLS Martin Rigid Fixation - Sterile; K062570: Individual Patient Solutions - Ti (IPS-Ti); K072707: Individual Patient Solutions - PEEK (IPS-PEEK) ; K151382: Individual Patient Solutions - (IPS-PEEK) - STERILEKLS-Martin L.P.Nov 10, 2025Traditional
K240567CustomizedBone ServiceFin-Ceramica Faenza S.P.A.Mar 28, 2024Special
K231920Longeviti ClearFit OTS Cranial ImplantLongeviti Neuro Solutions, LLCNov 9, 2023Special
K214109PEEK Patient Specific Cranial/Craniofacial Implant(PSCI)Kontour(Xi’An) Medical Technology Co., Ltd.Oct 28, 2022Traditional
K220357MedCAD AccuShape Titanium Patient-Specific Cranial ImplantMedcadAug 26, 2022Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 57 with a free account)

Clearances by year

34 GXN 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)4193
20252217
2024128
20231133
20222251
2021369
2020533
20183199
20172189
20161278
20152161
20142451
20131232
20123102
20112116

Who submits

21 applicants cleared a GXN device since 2011. 65% of the clearances went to applicants in United States, then Italy (15%), South Korea (6%) and Thailand (6%). By type: Traditional 79% and Special 21%.

ApplicantClearances since 2011
Longeviti Neuro Solutions, LLC7
Fin-Ceramica Faenza S.P.A.5
Kelyniam Global, Inc.2
Meticuly Co., Ltd.2
Osteosymbionics, LLC2
Aesculap, Inc.1
Bioarchitects USA, LLC1
CG Bio Co., Ltd.1

How FDA classifies it

Class II (performance standards).

From 21 CFR 882.5330.

Standards

21 CFR 882.5330 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GXN clearances declared.

Ask about GXN

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about GXN

What is FDA product code GXN?

Product code GXN, “Plate, Cranioplasty, Preformed, Non-Alterable” in FDA's classification database, is a Class II device type under 21 CFR 882.5330 (preformed nonalterable cranioplasty plate), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 57 clearances under GXN, 34 of them since 2011.

How many 510(k) clearances are there under GXN?

FDA’s 510(k) database listed 57 clearances under GXN as of Oct 29, 2026, 34 of them decided since 2011; the most recent decision was Jun 25, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a GXN 510(k)?

For the 6 GXN clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 193 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most GXN clearances?

Since 2011: Longeviti Neuro Solutions, LLC (7), Fin-Ceramica Faenza S.P.A. (5), Kelyniam Global, Inc. (2), Meticuly Co., Ltd. (2) and Osteosymbionics, LLC (2). 21 applicants have cleared a GXN device in that time.

Sources

  1. FDA product classification: GXN · Product Classification database
  2. 21 CFR 882.5330: Preformed nonalterable cranioplasty plate · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for GXN · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow GXNGet an email when FDA clears, recalls or publishes guidance for GXN devices.

Know what FDA already cleared.